UP under Yogi govt emerges as pharma hub: 17 companies pledge ₹2,000 crore investment, Barabanki to host biggest project

The latest NFHS-6 report shows major improvement in Uttar Pradesh across healthcare, women’s empowerment, education, family planning and access to basic facilities.
Uttar Pradesh Chief Minister Yogi Adityanath (Image via Money Control)

The Uttar Pradesh government, led by Chief Minister Yogi Adityanath, is stepping up efforts to strengthen the pharmaceutical and medical devices sector in the state. In a major push, 17 companies have committed to invest around ₹2,000 crore, a move expected to generate nearly 10,000 jobs for young people.

On Sunday, 26th April, the Chief Minister handed over Letters of Comfort to representatives of these companies, marking the formal start of their investment plans. These firms will set up manufacturing units and plants across different districts of the state.

‘UP becoming a preferred investment destination’

Speaking at the event, CM Yogi said that Uttar Pradesh is now becoming a symbol of security, stability, and fast-paced development for investors. He added that industries investing in the state are being given timely approvals and full administrative support.

“Today, Uttar Pradesh has emerged as an investment hub. Continuous improvements in law and order and infrastructure have made the state more attractive for industries,” he said, adding that the government is committed to turning UP into an “Uttam Pradesh”.

Investments spread across key districts 

The proposed investments will be spread across multiple districts, including Noida, Ghaziabad, Kanpur, Aligarh, Bareilly, and Saharanpur, among others.

The largest investment, of approximately ₹1,250 crore, is proposed by Biogenta Lifescience Private Limited in the Barabanki district. Several other organisations are expected to establish medium-sized and smaller plants within the state.

17 companies receive letters of comfort 

Among the investors are companies such as Romans Medworld, Hygience Laboratories, Kotech Healthcare, JB Remedies, Positron Biogenics, and IV Tech Healthcare. These organisations are planning to invest in various parts of the pharmaceutical and medical devices industry.

Government officials claim that the issuance of letters of comfort signifies that the government is ready to assist these projects.

Pharma and medical device parks in focus  

The state government is also developing large industrial clusters to support the sector. A 1,500-acre pharma park is being planned in Lalitpur, while a 350-acre medical device park is coming up in Noida. More than 100 companies have already shown interest in or joined these projects.

The Chief Minister highlighted that Uttar Pradesh is not only India’s largest consumer market but also has a young population, with nearly 56% of its people in the working-age group. The government is focusing on skill development, innovation, and technology to prepare this workforce for new opportunities.

The state has received investment proposals worth around ₹45 lakh crore so far. Out of this, projects worth ₹15 lakh crore are already under implementation, while another ₹7-8 lakh crore worth of investments are expected to be grounded soon.

Officials believe that the new investments in the pharma sector will not only boost industrial development but also create quality jobs and strengthen the state’s economy in the coming years.

Written by OpIndia Staff
Last modified at